2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS is a paper indexed in ScholarIQ from OpenAlex.
How many citations does 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS have?
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS has 2,996 citations in the OpenAlex counts ScholarIQ stores.
When was 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS published?
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS has 2017 year in the ScholarIQ index.
What is the open-access status of 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS?
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS has bronze oa status in the ScholarIQ index.
What is the DOI of 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS?
The DOI for 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS is on the source record.
What is the PMID of 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS?
The PMID for 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS is on the source record.
What is the OpenAlex record for 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS?
The OpenAlex for 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS is on the source record.